ID29286A - Pemasukan zat-zat aktif pada matriks pembawa - Google Patents

Pemasukan zat-zat aktif pada matriks pembawa

Info

Publication number
ID29286A
ID29286A IDW20001991A ID20001991A ID29286A ID 29286 A ID29286 A ID 29286A ID W20001991 A IDW20001991 A ID W20001991A ID 20001991 A ID20001991 A ID 20001991A ID 29286 A ID29286 A ID 29286A
Authority
ID
Indonesia
Prior art keywords
introduction
active materials
carrier matrix
matrix
carrier
Prior art date
Application number
IDW20001991A
Other languages
English (en)
Indonesian (id)
Inventor
Marie Luise Anderson
Catherine Boissier
Anne Marie Juppo
Anette Larson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ID29286A publication Critical patent/ID29286A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D11/00—Solvent extraction
    • B01D11/04—Solvent extraction of solutions which are liquid
    • B01D11/0403—Solvent extraction of solutions which are liquid with a supercritical fluid
    • B01D11/0411—Solvent extraction of solutions which are liquid with a supercritical fluid the supercritical fluid acting as solvent for the solvent and as anti-solvent for the solute, e.g. formation of particles from solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nozzles (AREA)
  • General Preparation And Processing Of Foods (AREA)
IDW20001991A 1998-04-14 1999-04-09 Pemasukan zat-zat aktif pada matriks pembawa ID29286A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9801287A SE9801287D0 (sv) 1998-04-14 1998-04-14 Incorporation of active substances in carrier matrixes

Publications (1)

Publication Number Publication Date
ID29286A true ID29286A (id) 2001-08-16

Family

ID=20410946

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001991A ID29286A (id) 1998-04-14 1999-04-09 Pemasukan zat-zat aktif pada matriks pembawa

Country Status (31)

Country Link
US (1) US6372260B1 (cs)
EP (1) EP1069890B1 (cs)
JP (1) JP2002511400A (cs)
KR (1) KR100600691B1 (cs)
CN (1) CN1201728C (cs)
AR (1) AR019262A1 (cs)
AT (1) ATE329580T1 (cs)
AU (1) AU744874B2 (cs)
BR (1) BR9909636A (cs)
CA (1) CA2327522C (cs)
CY (1) CY1105154T1 (cs)
CZ (1) CZ20003784A3 (cs)
DE (1) DE69931904T2 (cs)
DK (1) DK1069890T3 (cs)
EE (1) EE200000595A (cs)
ES (1) ES2267268T3 (cs)
HU (1) HUP0102305A3 (cs)
ID (1) ID29286A (cs)
IL (1) IL138635A0 (cs)
IS (1) IS5656A (cs)
NO (1) NO329145B1 (cs)
NZ (1) NZ507190A (cs)
PL (1) PL344077A1 (cs)
PT (1) PT1069890E (cs)
RU (1) RU2208435C2 (cs)
SE (1) SE9801287D0 (cs)
SK (1) SK14112000A3 (cs)
TR (1) TR200002960T2 (cs)
TW (1) TW542724B (cs)
WO (1) WO1999052507A1 (cs)
ZA (1) ZA992549B (cs)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761909B1 (en) * 1999-12-21 2004-07-13 Rxkinetix, Inc. Particulate insulin-containing products and method of manufacture
WO2001045731A1 (en) * 1999-12-21 2001-06-28 Rxkinetix, Inc. Particulate drug-containing products and method of manufacture
GB0102075D0 (en) * 2001-01-26 2001-03-14 Astrazeneca Ab Process
FR2824754B1 (fr) * 2001-05-15 2004-05-28 Separex Sa Procede d'obtention de particules solides a partir d'au moins un produit hydrosoluble
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
KR100979877B1 (ko) * 2001-09-28 2010-09-02 뉴트라슈틱스 인코포레이티드 생물학적 성분의 전달 시스템
US20070098784A1 (en) 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
US6998051B2 (en) * 2002-07-03 2006-02-14 Ferro Corporation Particles from supercritical fluid extraction of emulsion
GB0216780D0 (en) * 2002-07-19 2002-08-28 Bradford Particle Design Ltd Methods of particle formation
US6966990B2 (en) 2002-10-11 2005-11-22 Ferro Corporation Composite particles and method for preparing
US7083748B2 (en) * 2003-02-07 2006-08-01 Ferro Corporation Method and apparatus for continuous particle production using supercritical fluid
US6931888B2 (en) 2003-02-07 2005-08-23 Ferro Corporation Lyophilization method and apparatus for producing particles
US7455797B2 (en) * 2003-02-28 2008-11-25 Ferro Corporation Method and apparatus for producing particles using supercritical fluid
US20060182808A1 (en) * 2003-04-29 2006-08-17 Akzo Nobel N.V. Antisolvent solidification process
AU2004237131B2 (en) 2003-05-08 2009-09-10 Nektar Therapeutics Particulate materials
US20060008531A1 (en) * 2003-05-08 2006-01-12 Ferro Corporation Method for producing solid-lipid composite drug particles
WO2005022603A2 (en) * 2003-09-02 2005-03-10 Integral Technologies, Inc. Low cost conductive containers manufactured from conductive loaded resin-based materials
GB0602637D0 (en) * 2006-02-09 2006-03-22 Glaxo Group Ltd Novel process
NL1031224C2 (nl) * 2006-02-23 2007-09-03 Friesland Brands Bv Het bereiden van gedroogde deeltjes met behulp van een superkritisch medium.
WO2007133750A2 (en) * 2006-05-12 2007-11-22 The Board Of Trustees Of The Leland Stanford Junior University Encapsulated nanoparticles for drug delivery
FR2900845B1 (fr) 2006-05-15 2009-03-06 Commissariat Energie Atomique Procede et dispositif de synthese de particules organiques ou inorganiques enrobees
EP1913955A1 (en) 2006-10-19 2008-04-23 Gerhard, Markus Novel method for treating H.pylori infections
US20080260852A1 (en) * 2007-01-23 2008-10-23 Ferro Pfanstiehl Laboratories, Inc. Supercritical fluid extraction produced by in-line homogenization
US7745566B2 (en) * 2007-01-23 2010-06-29 Ferro Corporation Methods for the purification of polymers
AU2008214205B2 (en) 2007-02-11 2014-04-24 Map Pharmaceuticals, Inc. Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
EP3272354A1 (en) 2016-07-20 2018-01-24 Technische Universität München Agents and methods for the prevention or treatment of h. pylori infections
KR102170146B1 (ko) * 2019-03-05 2020-10-26 서울대학교산학협력단 Pca 공정을 이용한 배양액의 결정화 장치 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3744329A1 (de) * 1987-12-28 1989-07-06 Schwarz Pharma Gmbh Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
NZ233503A (en) * 1989-05-15 1991-06-25 Janssen Pharmaceutica Nv Substituted (thio)morpholinyl and piperazinyl alkylphenol ethers
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
US5091188A (en) * 1990-04-26 1992-02-25 Haynes Duncan H Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
US5639441A (en) 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation

Also Published As

Publication number Publication date
SK14112000A3 (sk) 2001-07-10
WO1999052507A1 (en) 1999-10-21
AU4066399A (en) 1999-11-01
DE69931904T2 (de) 2006-12-21
PL344077A1 (en) 2001-09-24
CZ20003784A3 (cs) 2001-08-15
EE200000595A (et) 2002-04-15
KR20010042660A (ko) 2001-05-25
NZ507190A (en) 2002-02-01
US6372260B1 (en) 2002-04-16
NO20005150D0 (no) 2000-10-13
BR9909636A (pt) 2000-12-19
CY1105154T1 (el) 2010-03-03
EP1069890B1 (en) 2006-06-14
HUP0102305A2 (hu) 2001-12-28
IS5656A (is) 2000-10-11
NO20005150L (no) 2000-12-08
ZA992549B (en) 1999-10-14
IL138635A0 (en) 2001-10-31
ES2267268T3 (es) 2007-03-01
CN1309555A (zh) 2001-08-22
PT1069890E (pt) 2006-09-29
TR200002960T2 (tr) 2000-12-21
KR100600691B1 (ko) 2006-07-19
CA2327522C (en) 2008-03-25
AU744874B2 (en) 2002-03-07
ATE329580T1 (de) 2006-07-15
DE69931904D1 (de) 2006-07-27
CA2327522A1 (en) 1999-10-21
RU2208435C2 (ru) 2003-07-20
SE9801287D0 (sv) 1998-04-14
AR019262A1 (es) 2002-02-13
CN1201728C (zh) 2005-05-18
DK1069890T3 (da) 2006-08-28
TW542724B (en) 2003-07-21
NO329145B1 (no) 2010-08-30
HUP0102305A3 (en) 2003-04-28
EP1069890A1 (en) 2001-01-24
JP2002511400A (ja) 2002-04-16

Similar Documents

Publication Publication Date Title
ID29286A (id) Pemasukan zat-zat aktif pada matriks pembawa
DE69817009D1 (de) Verkapseltes aktives material in einer alginatmatrix
ID22878A (id) Komposisi aktif secara terapi
DE69841509D1 (de) Lektrodenfomstück und elektrochemische elemente
DK1035820T3 (da) Absorberende artikel
DE69816178D1 (de) Absorbierender Artikel
DE69834883D1 (de) Absorbierender Artikel
DE69930351D1 (de) Klebstoffzusammensetzung und Klebeschicht
GB9706942D0 (en) Active matrix devices
DE69819481D1 (de) Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE69823360D1 (de) Feste arzneizubereitung enthaltend benzofuranderivate
DE69838196D1 (de) Absorbierender Artikel
IS5504A (is) Samsetning virk við meðhöndlun á getuleysi
DE69807267D1 (de) Absorbierender Artikel
DK0966243T3 (da) Absorberende artikel
FI972210L (fi) Hiostamaton materiaali
NO20016147L (no) Biologiske aktive materialer
EP1147186A4 (en) In vitro activated gamma delta lymphocytes
DE69904388D1 (de) Drucktuchträgermaterial beziehungsweise Drucktuch
DE69811979D1 (de) Absorbierender Artikel
DE60035089D1 (de) Verbindungs- und Trägerelement
DE69829236D1 (de) Zusammensetzungen enthaltendes biologisch aktives Silizium
DE69930738D1 (de) Oberflaechenaktive zusammensetzung
DE60034215D1 (de) Oberflaechenaktive zusammensetzung
DE69914937D1 (de) Betablocker und carbopol enthaltende ophtalmische zusammensetzung